Research & Literature

The management of uterine leiomyomas.

Lefebvre G, Vilos G, Allaire C, et al.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2003; (25(5)):396-418; quiz 419-22.

The management of uterine leiomyomas.

Vilos GA, Allaire C, Laberge PY, et al.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2015; (37(2)):157-178 doi:10.1016/S1701-2163(15)30338-8.

The management of uterine fibroids in women with otherwise unexplained infertility.

Carranza-Mamane B, Havelock J, Hemmings R, et al.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2015; (37(3)):277-285 doi:10.1016/S1701-2163(15)30318-2.

The medical management of abnormal uterine bleeding in reproductive-aged women.

Bradley LD, Gueye NA

American journal of obstetrics and gynecology 2016; (214(1)):31-44.

Review of nonsurgical/minimally invasive treatments and open myomectomy for uterine fibroids.

Chittawar PB, Kamath MS

Current opinion in obstetrics & gynecology 2015; (27(6)):391-7 doi:10.1097/GCO.0000000000000223.

Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.

Raine-Bennett T, Tucker LY, Zaritsky E, et al.

Obstetrics and gynecology 2016; (127(1)):29-39 doi:10.1097/AOG.0000000000001187.

Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.

Perkins RB, Handal-Orefice R, Hanchate AD, et al.

Women's health issues : official publication of the Jacobs Institute of Women's Health 2016; (26(1)):21-6.

Role of Medical Management for Uterine Leiomyomas.

Kashani BN, Centini G, Morelli SS, et al.

Best practice & research. Clinical obstetrics & gynaecology 2016; (34()):85-103.

Imaging techniques for evaluation of uterine myomas.

Testa AC, Di Legge A, Bonatti M, et al.

Best practice & research. Clinical obstetrics & gynaecology 2016; (34()):37-53.

Use of Ulipristal Acetate for the Management of Fibroid-Related Acute Abnormal Uterine Bleeding.

Arendas K, Leyland NA

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2016; (38(1)):80-3.

Income Inequities and Medicaid Expansion are Related to Racial and Ethnic Disparities in Delayed or Forgone Care Due to Cost.

Clark CR, Ommerborn MJ, A Coull B, et al.

Medical care 2016; (54(6)):555-61 doi:10.1097/MLR.0000000000000525.

Uncommon Complication of Uterine Artery Embolization: Expulsion of Infarcted Myoma and Uterine Sepsis.

Martins JG, Gaudenti D, Crespo F, et al.

Case reports in obstetrics and gynecology 2016; (2016()):8695318 doi:10.1155/2016/8695318.

The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions.

Penner LA, Dovidio JF, Gonzalez R, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; (34(24)):2874-80 doi:10.1200/JCO.2015.66.3658.

Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial.

de Bruijn AM, Ankum WM, Reekers JA, et al.

American journal of obstetrics and gynecology 2016; (215(6)):745.e1-745.e12 doi:10.1016/j.ajog.2016.06.051.

Is a history of cesarean section a risk factor for abnormal uterine bleeding in patients with uterine leiomyoma?

Kinay T, Basarir ZO, Tuncer SF, et al.

Saudi medical journal 2016; (37(8)):871-6 doi:10.15537/smj.2016.8.14711.

The role of leiomyomas in the genesis of abnormal uterine bleeding (AUB).

Lasmar RB, Lasmar BP

Best practice & research. Clinical obstetrics & gynaecology 2017; (40()):82-88 doi:10.1016/j.bpobgyn.2016.09.008.

Symptoms of uterine myomas: data of an epidemiological study in Germany.

Foth D, Röhl FW, Friedrich C, et al.

Archives of gynecology and obstetrics 2017; (295(2)):415-426 doi:10.1007/s00404-016-4239-y.

Uterine rupture in pregnancies following myomectomy: A multicenter case series.

Kim HS, Oh SY, Choi SJ, et al.

Obstetrics & gynecology science 2016; (59(6)):454-462 doi:10.5468/ogs.2016.59.6.454.

Two novel classification systems for uterine fibroids and subsequent uterine reconstruction after myomectomy.

Juhasz-Böss I, Jungmann P, Radosa J, et al.

Archives of gynecology and obstetrics 2017; (295(3)):675-680 doi:10.1007/s00404-016-4268-6.

Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis.

Barnard EP, AbdElmagied AM, Vaughan LE, et al.

American journal of obstetrics and gynecology 2017; (216(5)):500.e1-500.e11 doi:10.1016/j.ajog.2016.12.177.

Uterine Fibroids: Diagnosis and Treatment.

De La Cruz MS, Buchanan EM

American family physician 2017; (95(2)):100-107.

Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis.

Fuldeore MJ, Soliman AM

International journal of women's health 2017; (9()):403-411 doi:10.2147/IJWH.S133212.

Literature Review on the Role of Uterine Fibroids in Endometrial Function.

Ikhena DE, Bulun SE

Reproductive sciences (Thousand Oaks, Calif.) 2018; (25(5)):635-643 doi:10.1177/1933719117725827.

Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline.

,

Fertility and sterility 2017; (108(3)):416-425 doi:10.1016/j.fertnstert.2017.06.034.

Morcellation of occulted sarcomas during laparoscopic myomectomy and hysterectomy for patients with large fibroid uterus.

Tinelli A, Farghaly SA

Minerva ginecologica 2018; (70(1)):84-88 doi:10.23736/S0026-4784.17.04149-1.

Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.

Wu X, Serna VA, Thomas J, et al.

Cancer research 2017; (77(24)):6891-6901 doi:10.1158/0008-5472.CAN-17-1744.

Medical therapy for fibroids: An overview.

Sinai Talaulikar V

Best practice & research. Clinical obstetrics & gynaecology 2018; (46()):48-56 doi:10.1016/j.bpobgyn.2017.09.007.

Adverse obstetric outcomes in pregnant women with uterine fibroids in China: A multicenter survey involving 112,403 deliveries.

Zhao R, Wang X, Zou L, et al.

PloS one 2017; (12(11)):e0187821 doi:10.1371/journal.pone.0187821.

Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.

Jamaluddin MFB, Ko YA, Kumar M, et al.

Endocrinology 2018; (159(2)):1106-1118 doi:10.1210/en.2017-03018.

Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.

Park MJ, Shen H, Spaeth JM, et al.

The Journal of biological chemistry 2018; (293(13)):4870-4882 doi:10.1074/jbc.RA118.001725.

Ultrasonography of uterine leiomyomas.

Woźniak A, Woźniak S

Przeglad menopauzalny = Menopause review 2017; (16(4)):113-117 doi:10.5114/pm.2017.72754.

Current medical treatment of uterine fibroids.

Sohn GS, Cho S, Kim YM, et al.

Obstetrics & gynecology science 2018; (61(2)):192-201 doi:10.5468/ogs.2018.61.2.192.

Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis.

Sandberg EM, Tummers FHMP, Cohen SL, et al.

Fertility and sterility 2018; (109(4)):698-707.e1 doi:10.1016/j.fertnstert.2017.11.033.

Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada.

Rattray DD, Weins L, Regush LC, et al.

ClinicoEconomics and outcomes research : CEOR 2018; (10()):201-212 doi:10.2147/CEOR.S155038.

A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma.

Lewis TD, Malik M, Britten J, et al.

BioMed research international 2018; (2018()):2414609 doi:10.1155/2018/2414609.

Adenomyosis: A Sonographic Diagnosis.

Cunningham RK, Horrow MM, Smith RJ, Springer J

Radiographics : a review publication of the Radiological Society of North America, Inc 2018; (38(5)):1576-1589 doi:10.1148/rg.2018180080.

A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.

Yu O, Scholes D, Schulze-Rath R, et al.

American journal of obstetrics and gynecology 2018; (219(6)):591.e1-591.e8 doi:10.1016/j.ajog.2018.09.039.

Management of fibroids prior to in vitro fertilization/intracytoplasmic sperm injection: A pragmatic approach

Sarıdoğan E, Sarıdoğan E

Journal of the Turkish German Gynecological Association 2019; (20(1)):55-59 doi:10.4274/jtgga.galenos.2018.2018.0148.

Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.

Multinu F, Casarin J, Tortorella L, et al.

American journal of obstetrics and gynecology 2019; (220(2)):179.e1-179.e10 doi:10.1016/j.ajog.2018.11.1086.

Evaluation of the routine use of pelvic MRI in women presenting with symptomatic uterine fibroids: When is pelvic MRI useful?

Vu KN, Fast AM, Shaffer RK, et al.

Journal of magnetic resonance imaging : JMRI 2019; (49(7)):e271-e281 doi:10.1002/jmri.26620.

FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery.

Laughlin-Tommaso S, Barnard EP, AbdElmagied AM, et al.

American journal of obstetrics and gynecology 2019; (220(2)):174.e1-174.e13 doi:10.1016/j.ajog.2018.10.032.

Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.

Osuga Y, Enya K, Kudou K, et al.

Obstetrics and gynecology 2019; (133(3)):423-433 doi:10.1097/AOG.0000000000003141.

Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.

Desai VB, Wright JD, Gross CP, et al.

American journal of obstetrics and gynecology 2019; (221(1)):39.e1-39.e14 doi:10.1016/j.ajog.2019.02.051.

Elagolix Suppresses Ovulation in a Dose-Dependent Manner: Results From a 3-Month, Randomized Study in Ovulatory Women.

Archer DF, Ng J, Chwalisz K, et al.

The Journal of clinical endocrinology and metabolism 2020; (105(3)) doi:10.1210/clinem/dgz086.

Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.

Laughlin-Tommaso SK, Lu D, Thomas L, et al.

American journal of obstetrics and gynecology 2020; (222(4)):345.e1-345.e22 doi:10.1016/j.ajog.2019.09.052.

Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies.

Bradley LD, Pasic RP, Miller LE

Journal of laparoendoscopic & advanced surgical techniques. Part A 2019; (29(12)):1507-1517 doi:10.1089/lap.2019.0550.

Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department.

Ramos JG, Zeller MP

Hematology. American Society of Hematology. Education Program 2019; (2019(1)):323-326 doi:10.1182/hematology.2019000079.

Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.

Schlaff WD, Ackerman RT, Al-Hendy A, et al.

The New England journal of medicine 2020; (382(4)):328-340 doi:10.1056/NEJMoa1904351.

Relationship between a uterine fibroid diagnosis and the risk of adverse obstetrical outcomes: a cohort study.

Karlsen K, Schiøler Kesmodel U, Mogensen O, et al.

BMJ open 2020; (10(2)):e032104 doi:10.1136/bmjopen-2019-032104.

Diagnosing adenomyosis: an integrated clinical and imaging approach.

Chapron C, Vannuccini S, Santulli P, et al.

Human reproduction update 2020; (26(3)):392-411 doi:10.1093/humupd/dmz049.

The impact of FIGO type 3 fibroids on in-vitro fertilization outcomes: A nested retrospective case-control study.

Bai X, Lin Y, Chen Y, Ma C

European journal of obstetrics, gynecology, and reproductive biology 2020; (247()):176-180 doi:10.1016/j.ejogrb.2019.12.018.

Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.

Simon JA, Al-Hendy A, Archer DF, et al.

Obstetrics and gynecology 2020; (135(6)):1313-1326 doi:10.1097/AOG.0000000000003869.

Uterine fibroids and preterm birth risk: A systematic review and meta-analysis.

Pérez-Roncero GR, López-Baena MT, Ornat L, et al.

The journal of obstetrics and gynaecology research 2020; (46(9)):1711-1727 doi:10.1111/jog.14343.

Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.

Al-Hendy A, Bradley L, Owens CD, et al.

American journal of obstetrics and gynecology 2021; (224(1)):72.e1-72.e50 doi:10.1016/j.ajog.2020.07.032.

Uterine-Artery Embolization or Myomectomy for Uterine Fibroids.

Manyonda I, Belli AM, Lumsden MA, et al.

The New England journal of medicine 2020; (383(5)):440-451 doi:10.1056/NEJMoa1914735.

Laparoscopic Power Morcellation: Techniques to Avoid Tumoral Spread.

Zapardiel I, Boria F, Halaska MJ, De Santiago J

Journal of minimally invasive gynecology 2021; (28(8)):1442-1443 doi:10.1016/j.jmig.2020.09.012.

Non-hysteroscopic Myomectomy and Fertility Outcomes: A Systematic Review.

Orlando M, Kollikonda S, Hackett L, Kho R

Journal of minimally invasive gynecology 2021; (28(3)):598-618.e1 doi:10.1016/j.jmig.2020.10.006.

Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).

Sangkomkamhang US, Lumbiganon P, Pattanittum P

The Cochrane database of systematic reviews 2020; (11()):CD008994 doi:10.1002/14651858.CD008994.pub3.

Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids.

Calderon L, Netter A, Grob-Vaillant A, et al.

Reproductive biomedicine online 2021; (42(3)):661-668 doi:10.1016/j.rbmo.2020.11.012.

Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroids.

Shifrin G, Engelhardt M, Gee P, Pschadka G

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2021; (155(1)):79-85 doi:10.1002/ijgo.13638.

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.

Al-Hendy A, Lukes AS, Poindexter AN, et al.

The New England journal of medicine 2021; (384(7)):630-642 doi:10.1056/NEJMoa2008283.

Fibroids and natural fertility: a systematic review and meta-analysis.

Somigliana E, Reschini M, Bonanni V, et al.

Reproductive biomedicine online 2021; (43(1)):100-110 doi:10.1016/j.rbmo.2021.03.013.

Wnt/β-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities.

El Sabeh M, Saha SK, Afrin S, et al.

Molecular and cellular biochemistry 2021; (476(9)):3513-3536 doi:10.1007/s11010-021-04174-6.

Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.

Obstetrics and gynecology 2021; (137(6)):e100-e115 doi:10.1097/AOG.0000000000004401.

Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.

Orellana M, Riggan KA, DSouza K, et al.

Journal of racial and ethnic health disparities 2022; (9(4)):1184-1191 doi:10.1007/s40615-021-01059-8.

Uterine Fibroids in Black Women: A Race-Stratified Subgroup Analysis of Treatment Outcomes After Laparoscopic Radiofrequency Ablation.

Berman JM, Bradley L, Hawkins SM, Levy B

Journal of women's health (2002) 2022; (31(4)):593-599 doi:10.1089/jwh.2020.9001.

Evidence that geographic variation in genetic ancestry associates with uterine fibroids.

Keaton JM, Jasper EA, Hellwege JN, et al.

Human genetics 2021; (140(10)):1433-1440 doi:10.1007/s00439-021-02322-y.

Molecular and Cellular Insights into the Development of Uterine Fibroids.

Machado-Lopez A, Simón C, Mas A

International journal of molecular sciences 2021; (22(16)) doi:10.3390/ijms22168483.

Do Large Uterine Fibroids Impact Pregnancy Outcomes?

Al Sulaimani R, Machado L, Al Salmi M

Oman medical journal 2021; (36(4)):e292 doi:10.5001/omj.2021.93.

Uterine artery embolization or myomectomy for women with uterine fibroids: Four-year follow-up of a randomised controlled trial.

Daniels J, Middleton LJ, Cheed V, et al.

European journal of obstetrics & gynecology and reproductive biology: X 2022; (13()):100139 doi:10.1016/j.eurox.2021.100139.

Radiofrequency Ablation of Uterine Myomas and Pregnancy Outcomes: An Updated Review of the Literature.

Polin M, Hur HC

Journal of minimally invasive gynecology 2022; (29(6)):709-715 doi:10.1016/j.jmig.2022.01.015.

Route of myomectomy and fertility: a prospective cohort study.

Wise LA, Thomas L, Anderson S, et al.

Fertility and sterility 2022; (117(5)):1083-1093 doi:10.1016/j.fertnstert.2022.01.013.

The Burden of Uterine Fibroids from the Perspective of US Women Participating in Open-Ended Interviews.

Hunsche E, Rakov V, Scippa K, et al.

Women's health reports (New Rochelle, N.Y.) 2022; (3(1)):286-296 doi:10.1089/whr.2021.0086.

Interdisciplinary model-informed drug development for extending duration of elagolix treatment in patients with uterine fibroids.

Beck D, Winzenborg I, Gao W, et al.

British journal of clinical pharmacology 2022; (88(12)):5257-5268 doi:10.1111/bcp.15440.

Uterine fibroids increase the risk of preterm birth and other adverse birth events: a systematic review and meta-analysis.

Wang X, Wang G, Han R, et al.

Translational pediatrics 2022; (11(6)):978-986 doi:10.21037/tp-22-215.

Advances in the Preoperative Identification of Uterine Sarcoma.

Liu J, Wang Z

Cancers 2022; (14(14)) doi:10.3390/cancers14143517.

Fibroids and Fertility: A Comparison of Myomectomy and Uterine Artery Embolization on Fertility and Reproductive Outcomes.

Zanolli NC, Bishop KC, Kuller JA, et al.

Obstetrical & gynecological survey 2022; (77(8)):485-494 doi:10.1097/OGX.0000000000001052.

Successful laparoscopic management of acute abdominal pain due to spontaneous rupture of subserosal vessels overlying a uterine fibroid: a case report and surgical video.

Maemura T, Fujita S, Morita N, et al.

BMC women's health 2022; (22(1)):388 doi:10.1186/s12905-022-01970-0.

Uterine disorders and iron deficiency anemia.

Donnez J, Carmona F, Maitrot-Mantelet L, et al.

Fertility and sterility 2022; (118(4)):615-624 doi:10.1016/j.fertnstert.2022.08.011.

Fibroids-related complications in pregnancy: a twelve-year long experience at a maternal-fetal medicine referral center.

Lazzarin S, Ornaghi S, Roncaglia N, et al.

Minerva obstetrics and gynecology 2023; (75(6)):520-525 doi:10.23736/S2724-606X.22.05146-6.

Clinical features at the time of non-hysteroscopic myomectomy before pregnancy, which affect adverse pregnancy outcomes: a retrospective cohort study.

Kim YR, Na ED, Jung JE, et al.

BMC pregnancy and childbirth 2022; (22(1)):896 doi:10.1186/s12884-022-05240-7.

Uterine Weight as a Modifier of Black/White Racial Disparities in Minimally Invasive Hysterectomy Among Veterans with Fibroids in the Veterans Health Administration.

Carey CM, Katon JG, Bossick AS, et al.

Health equity 2022; (6(1)):909-916 doi:10.1089/heq.2022.0130.

Racial disparities in uterine fibroids and endometriosis: a systematic review and application of social, structural, and political context.

Katon JG, Plowden TC, Marsh EE

Fertility and sterility 2023; (119(3)):355-363 doi:10.1016/j.fertnstert.2023.01.022.

Large Cervical Leiomyoma of the Uterus: A Rare Cause of Chronic Pelvic Pain Associated With Obstructive Uropathy and Renal Dysfunction: A Case Report.

Thanasa E, Thanasa A, Kamaretsos E, et al.

Cureus 2023; (15(1)):e33387 doi:10.7759/cureus.33387.

The effect of ≤6 cm sized noncavity-distorting intramural fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis.

Erden M, Uyanik E, Polat M, et al.

Fertility and sterility 2023; (119(6)):996-1007 doi:10.1016/j.fertnstert.2023.02.018.

Asherman Syndrome after Uterine Artery Embolization: A Cohort Study about Surgery Management and Fertility Outcomes.

Jegaden M, Bleas C, Debras E, et al.

Journal of minimally invasive gynecology 2023; (30(6)):494-501 doi:10.1016/j.jmig.2023.02.012.

A huge prolapsed cervical leiomyoma: A case report.

Zemni I, Aloui M, Saadallah F, et al.

International journal of surgery case reports 2023; (106()):108139 doi:10.1016/j.ijscr.2023.108139.

Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.

Neblett MF, Stewart EA

Obstetrics and gynecology 2023; (141(5)):901-910 doi:10.1097/AOG.0000000000005145.

Smooth Muscle Tumors of the Uterus at MRI: Focus on Leiomyomas and FIGO Classification.

Tu W, Yano M, Schieda N, et al.

Radiographics : a review publication of the Radiological Society of North America, Inc 2023; (43(6)):e220161 doi:10.1148/rg.220161.

The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review.

Amendola ILS, Spann M, Segars J, Singh B

Reproductive sciences (Thousand Oaks, Calif.) 2024; (31(2)):291-308 doi:10.1007/s43032-023-01297-7.

LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.

Al-Hendy A, Venturella R, Arjona Ferreira JC, et al.

American journal of obstetrics and gynecology 2023; (229(6)):662.e1-662.e25 doi:10.1016/j.ajog.2023.08.030.

Uterine fibroid-related infertility: mechanisms and management.

Donnez J, Taylor HS, Marcellin L, Dolmans MM

Fertility and sterility 2024; (122(1)):31-39 doi:10.1016/j.fertnstert.2024.02.049.

The influence of uterine fibroids on adverse outcomes in pregnant women: a meta-analysis.

Li H, Hu Z, Fan Y, Hao Y

BMC pregnancy and childbirth 2024; (24(1)):345 doi:10.1186/s12884-024-06545-5.

The modern management of uterine fibroids-related abnormal uterine bleeding.

Vannuccini S, Petraglia F, Carmona F, et al.

Fertility and sterility 2024; (122(1)):20-30 doi:10.1016/j.fertnstert.2024.04.041.

Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities.

Bateman NW, Abulez T, Tarney CM, et al.

American journal of obstetrics and gynecology 2024; (231(3)):321.e1-321.e11 doi:10.1016/j.ajog.2024.04.051.

Clinical signs and diagnosis of fibroids from adolescence to menopause.

Mension E, Carmona F, Vannuccini S, Chapron C

Fertility and sterility 2024; (122(1)):12-19 doi:10.1016/j.fertnstert.2024.05.003.

Abnormal uterine bleeding: The well-known and the hidden face.

Leal CRV, Vannuccini S, Jain V, et al.

Journal of endometriosis and uterine disorders 2024; (6()) doi:10.1016/j.jeud.2024.100071.

Preterm birth and uterine fibroid necrosis: The clinical presentation illustrated in a case series.

Don EE, Vissers G, Landman AJEMC, et al.

European journal of obstetrics, gynecology, and reproductive biology 2024; (299()):156-162 doi:10.1016/j.ejogrb.2024.06.002.

Tailoring the Diagnostic Pathway for Medical and Surgical Treatment of Uterine Fibroids: A Narrative Review.

Centini G, Cannoni A, Ginetti A, et al.

Diagnostics (Basel, Switzerland) 2024; (14(18)) doi:10.3390/diagnostics14182046.

Uterine fibroids with heavy menstrual bleeding stratified by race in a commercial and Medicaid database.

Agarwal SK, Stokes M, Chen R, Lickert C

AJOG global reports 2024; (4(4)):100412 doi:10.1016/j.xagr.2024.100412.

Reproductive outcomes of high-intensity focused ultrasound ablation and myomectomy for uterine fibroids: a systematic review and meta-analysis.

Chen Y, Yi J, Lin S, et al.

Reproductive biomedicine online 2025; (50(1)):104436 doi:10.1016/j.rbmo.2024.104436.

The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications.

Barretta M, Vignali M, La Marca A, Grandi G

Expert opinion on drug metabolism & toxicology 2024; 1-13 doi:10.1080/17425255.2024.2441981.

European Society for Gynaecological Endoscopy (ESGE) Good Practice Recommendations on surgical techniques for Removal of Fibroids: Part 2 Hysteroscopic Myomectomy.

Clark TJ, Antoun L, Di Spiezio Sardo A, et al.

Facts, views & vision in ObGyn 2024; (16(4)):383-397 doi:10.52054/FVVO.16.4.054.

The feasibility of high-resolution organ-axial T2-weighted MRI when combined with federation of gynecology and obstetrics (FIGO) classification of uterine fibroid patients.

Liu X, Wang K, Gou X, et al.

Abdominal radiology (New York) 2025; (50(8)):3764-3772 doi:10.1007/s00261-024-04776-w.

Uterine Fibroid Diagnosis by Race and Ethnicity in an Integrated Health Care System.

Mitro SD, Dyer W, Lee C, et al.

JAMA network open 2025; (8(4)):e255235 doi:10.1001/jamanetworkopen.2025.5235.

UTERINE FIBROIDS.

Bulun SE, Yin P, Wei J, et al.

Physiological reviews 2025; (105(4)):1947-1988 doi:10.1152/physrev.00010.2024.

Impact of fibroids on fertility, pregnancy loss, and preconception management.

Ezike O, Schneyer R, Wright K, Hamilton K

Current opinion in obstetrics & gynecology 2025; (37(4)):207-214 doi:10.1097/GCO.0000000000001033.

Do myomectomies alter third-trimester complications compared with women without myomectomies and uterine fibroids in situ: A retrospective cohort study of an American population database.

Ginod P, Badeghiesh A, Baghlaf H, Dahan MH

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2025; (171(1)):310-316 doi:10.1002/ijgo.70211.

Unveiling the role of extracellular vesicles in reproductive success and uterine diseases - a systematic review.

Merino-Pérez A, Segura-Benítez M, Pellicer A, et al.

Reproductive biomedicine online 2025; (51(1)):104862 doi:10.1016/j.rbmo.2025.104862.

Guideline No. 461: The Management of Uterine Fibroids.

Chen I, Kives S, Randle E, et al.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2025; (47(8)):102970 doi:10.1016/j.jogc.2025.102970.

Diagnosis and classification of uterine fibroids.

Lakabi R, Harth S, Meinhold-Heerlein I, et al.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2025; (171(2)):566-573 doi:10.1002/ijgo.70538.

Impact of Uterine Artery Embolization on Subsequent Fertility Outcomes: A Meta-Analysis of 20 Years of Clinical Evidence.

Bucuri CE, Mihu D, Măluțan AM, et al.

Journal of clinical medicine 2025; (14(20)) doi:10.3390/jcm14207205.

Spontaneous Hemoperitoneum From a Ruptured Vessel Overlying a Sub-Serosal Myoma: A Rare and Life-Threatening Emergency in Women.

Adomako EK, Quao NS, Opare JN, Dordunoo M

Clinical case reports 2025; (13(11)):e71366 doi:10.1002/ccr3.71366.

Fibroids and pregnancy.

Ramasauskaite D, Purandare N, Diaz I, et al.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2026; (172(1)):51-58 doi:10.1002/ijgo.70612.

Recovery After Transcervical Fibroid Ablation Versus Minimally Invasive Myomectomy for Symptomatic Uterine Fibroids: A Randomised Controlled Trial.

Neis F, Kraemer B, Bauer A, et al.

BJOG : an international journal of obstetrics and gynaecology 2026; (133(4)):618-625 doi:10.1111/1471-0528.70081.

Mechanical Stiffness Influences the Response of Human Uterine Fibroid Cells to Hormonal Treatments.

Bariani MV, Djibrila E, Maajid E, et al.

Reproductive sciences (Thousand Oaks, Calif.) 2026; (33(1)):129-140 doi:10.1007/s43032-025-02016-0.

A Proposed Model of a Pragmatic Surgical Approach in Women Affected by Uterine Fibroids Undergoing IVF: A "Real Practice" Experience.

Antonaci D, Galanti F, Dall'Alba R, et al.

Journal of clinical medicine 2026; (15(1)) doi:10.3390/jcm15010379.

Fibroids and health disparities: the COllaboration for EQuity in Uterine Leiomyomas specialized center.

Stewart EA, Venable S, Borah BJ, et al.

American journal of obstetrics and gynecology 2026; (234(6)):1623-1628 doi:10.1016/j.ajog.2025.12.068.

Fibroids and infertility.

Mocanu E, Tarlatzis B, Feldberg D, et al.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2026; (174(1)):11-16 doi:10.1002/ijgo.71062.

Partially Expelled Necrotic Uterine Fibroid After Relugolix Combination Therapy: Case Report and Literature Overview on Adverse Effects of GnRH Antagonists.

Vona L, Pitsillidi A, Noé G, Bettocchi S

Case reports in obstetrics and gynecology 2026; (2026()):1926623 doi:10.1155/crog/1926623.

Surgical management of uterine fibroids.

Lewis JM, Wu H, Rojas AC, et al.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2026; (174(2)):554-578 doi:10.1002/ijgo.71123.